# GPT-5.4 (R1) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-26T13:05:56.910786
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 13281 in / 5318 out
**Response SHA256:** 4f1f8f390d22a9b9

---

This paper studies whether the 2019 Illinois Supreme Court decision in *Rosenbach v. Six Flags*—which made BIPA privately enforceable without proof of actual injury—reduced employment in industries with greater biometric exposure. The paper uses county-sector-quarter QCEW data for Illinois and neighboring states and estimates a continuous-exposure triple-difference, where treatment intensity is an O*NET-based sectoral biometric exposure index.

The paper has an interesting question, a potentially important policy setting, and a design that is intuitively appealing. The core idea—using a discrete legal shock plus cross-industry exposure heterogeneity in a border-county design—is promising and could yield a publishable paper. However, in its current form, the paper is not publication-ready for a top general-interest journal or AEJ: Economic Policy. The main reasons are (i) unresolved identification concerns, especially a nontrivial pre-trend/anticipation issue and unclear control-group validity, and (ii) weak statistical inference due to only six state clusters, with randomization-inference results that do not support the very strong conventional-significance claims in the paper. These are not cosmetic problems: they affect whether the main causal claim is established.

## 1. Identification and empirical design

### A. The design is sensible in principle, but the identifying assumption is not yet convincing

The proposed estimand is the coefficient on Illinois × Post × Exposure in equation (1) (Section 4). For this to have a causal interpretation, the paper needs a credible version of a DDD parallel-trends assumption: absent *Rosenbach*, relative employment trends across high- and low-exposure sectors would have evolved similarly in Illinois and neighboring states.

The paper is transparent that this assumption is problematic. The event study shows “a localized positive deviation” in 2018, and the placebo treatment in 2017Q1 is significant (+6.5%, p = 0.022; Section 6, Table 3). That is a serious warning sign. The paper argues that this is “localized” rather than secular, and that dropping 2017–2018 restores the result. But for a paper making a strong causal claim, this is not enough. A significant placebo in a relatively short pre-period is direct evidence against the maintained identifying assumption in the baseline design.

Two features make this especially consequential:

1. The treatment is a single-state legal shock, so the design already relies heavily on control-group comparability.
2. The treatment intensity is measured at the sector level, so any Illinois-specific sectoral divergence correlated with the exposure measure can load directly onto the triple interaction.

At minimum, the paper should treat the trimmed-window estimate as the main specification, not as a secondary robustness check. More importantly, it should do more to establish whether the 2018 movement is anticipation related to the case, unrelated Illinois-sector dynamics, or a symptom of broader nonparallel trends.

### B. Timing/anticipation is not fully coherent

The paper codes treatment as beginning in 2019Q1, the quarter of the January 25, 2019 decision. But the paper itself notes that oral arguments occurred in May 2018 and suggests anticipation as one possible explanation for the 2018 bump (Section 6). If firms plausibly anticipated a higher enforcement risk in 2018, then the treatment timing is not cleanly binary at 2019Q1.

This matters because the paper’s interpretation is built around a “single judicial reinterpretation” causing a break exactly at 2019Q1. That claim is too sharp given the evidence presented. If the ruling was partially anticipated, the event-study path and treatment coding need to reflect that.

A stronger paper would:
- explicitly test alternative treatment dates tied to litigation milestones,
- show whether the estimate emerges only at 2019Q1 or more gradually,
- distinguish between “activation at ruling” and “rising expected enforcement during the appellate process.”

### C. Border-county logic is plausible, but the control-group story is incomplete

The border-county design is motivated by labor-market comparability and potential adjustment at state borders. This is plausible. However, the paper’s own additional analysis complicates the mechanism: neighboring-state border counties also show negative post effects in high-exposure sectors (Appendix, Section “Border concentration”: neighbor-border coefficient = -0.082, p = 0.005). That is difficult to reconcile with a simple cross-border reallocation story.

This result does not kill the paper, but it weakens the interpretation that the border design isolates Illinois-specific adjustment relative to unaffected nearby controls. It suggests either:
- broader region-wide shocks to exposed sectors,
- spillovers from Illinois to neighboring border economies,
- measurement/design issues in the exposure-based specification,
- or some omitted post-2019 shock correlated with exposed sectors in the Midwest border region.

The current text acknowledges this, but does not resolve it. In a top-journal version, I would want a much more developed discussion and sharper empirical investigation:
- state-specific sector trends,
- border-pair analyses,
- county-pair or commuting-zone comparisons,
- tests using interior counties in neighboring states,
- and a map or formal sample-construction discussion that clarifies exactly what “border counties” buy the design beyond the all-counties null.

### D. The all-counties null materially limits the scope of the claim

The all-counties specification is small and insignificant (-1.9%; Table 1). Yet the abstract and conclusion state broad claims about labor-market effects and “first-order employment consequences.” The evidence is much more specific: at most, the paper identifies a border-localized effect, and even that estimate depends on how one handles pre-trends and inference.

This is important for interpretation. If the effect does not appear in the full state sample, then either:
- the effect is truly concentrated where cross-state adjustment margins are most available, or
- the border design is picking up local confounds.

Either way, the paper should calibrate its claim to “border labor markets” unless it can explain why the statewide null is still consistent with a substantial aggregate treatment effect.

### E. Exposure measurement raises identification concerns

The continuous treatment is central to the paper, but the exposure index is not yet convincing as a treatment-intensity proxy for litigation risk.

Key concerns:

1. **Post-treatment measurement.** The index is built using O*NET version 29.1 from March 2025 (Section 3 and appendix). The paper argues this captures slow-moving occupational characteristics rather than endogenous post-treatment behavior. That is possible, but not enough. A post-treatment exposure measure invites concern that sectoral technological content or task descriptions could themselves reflect post-2019 adaptation. A top-journal paper should either reconstruct the measure using pre-treatment O*NET vintages or show that the ranking is stable across vintages.

2. **Construct validity.** The appendix states that the IT-intensity component contributes zero variation, so the index is effectively driven entirely by keyword prevalence plus ad hoc preemption discounts. That makes the measure substantially more mechanical and potentially noisy than the main text suggests.

3. **Mismatch with realized litigation targeting.** Administrative Services has exposure 0.97 but a null sectoral effect; this is not a small discrepancy but a major challenge to the exposure measure’s validity. The paper responds by excluding the sector, which mechanically strengthens the estimate. That is not a satisfying solution. If one of the highest-exposure sectors is not actually exposed in the way relevant for the legal shock, then the treatment-intensity measure needs redesign, not selective trimming.

4. **Very coarse support.** The main continuous-treatment variation comes from only nine two-digit sectors. In practice, the estimate is identified off a small number of sector-level exposure values, one of which (Information) appears especially influential. This is not fatal, but it substantially limits how much weight one should put on the exact functional-form interpretation (“one-unit increase in exposure reduces employment by 11.7%”).

A stronger paper would validate the exposure measure against pre-*Rosenbach* technology adoption, actual BIPA defendant industry composition, or independent data on fingerprint time clocks / biometric use. At present, the exposure proxy looks too indirect for the strength of the causal and mechanism claims.

### F. Threats from contemporaneous shocks are not fully ruled out

The paper discusses COVID and adds sector × quarter fixed effects (Section 6). That is useful. But the core identification threat is not just nationwide sector shocks; it is Illinois-specific sector-by-time shocks correlated with the exposure index. The current specification absorbs national quarter shocks and county-sector fixed effects, but not state-specific sectoral trends or state-specific sector-by-post differentials beyond the exposure interaction.

Given the localized pre-trend and the border-only result, I would want to see much more:
- Illinois × sector linear trends, with careful interpretation,
- state × quarter fixed effects in specifications that use non-Illinois variation appropriately,
- border-pair × quarter fixed effects if feasible,
- or matched county-pair designs across state borders.

The current “linear trend kills the effect” result is brushed away as overcorrection. Maybe so, but once a linear differential trend eliminates the effect and a pre-treatment placebo is significant, the burden of proof shifts to the authors.

## 2. Inference and statistical validity

This is the paper’s most serious weakness.

### A. Main inference is not reliable with six state clusters

The main tables report conventional clustered standard errors at the state level with only six clusters (Illinois + five neighbors; Section 4, Tables 1–3). That is not credible for publication as the basis for strong significance claims like p < 0.001 or p = 0.016. With so few clusters, conventional cluster-robust asymptotics are known to be unreliable and often over-reject.

The paper acknowledges this, but then still foregrounds the conventional p-values in the abstract, introduction, and conclusions. That is not acceptable. Once the number of clusters is this small, the paper must elevate finite-sample-appropriate inference to primary status.

### B. The randomization-inference results are much weaker than the paper’s conventional claims

The paper reports randomization-inference p-values of:
- 0.167 for state permutation,
- 0.077 for timing permutation
(Table 3 and Appendix).

These are not minor details; they are the most credible inferential evidence in the paper. Under the state permutation, the result is not conventionally significant. Under timing permutation, it is only marginal at 10%. Yet the abstract emphasizes p < 0.001 and presents the findings as “striking.” That is a mismatch between evidence and rhetoric.

Moreover, the state-permutation exercise has very low resolution (minimum p = 1/6), which the paper notes. But that does not rescue the conventional inference—it simply means the design is intrinsically underpowered for exact inference at the state level. This limitation should substantially temper the paper’s claims.

### C. Sector-specific significance claims are especially fragile

Table 2 reports sector-by-sector DiD estimates, each with standard errors clustered at the state level. These are even less reliable than the pooled specification because each sectoral regression is based on the same six clusters and smaller samples. Claims that Information, Management, and Professional Services are “significant” should not be made on the basis of these p-values.

At most, Table 2 should be presented descriptively unless the paper provides valid small-cluster inference for each specification.

### D. The paper should use small-cluster methods as primary inference

For a credible revision, the authors should rework inference using methods suited to few treated/control clusters, such as:
- wild cluster bootstrap-t,
- randomization/permutation tests tailored to the assignment mechanism,
- Conley-Taber style approaches for policy shocks with few treated groups where appropriate,
- and/or randomization inference over state-time placebo assignments as the primary inferential framework.

The exact choice matters less than the principle: the current star-based inference cannot be the basis of publication.

### E. Sample sizes are mostly coherent, but some reported inferential choices are inconsistent

The sample counts are generally coherent across tables. But there are some concerns:
- The paper switches in one appendix regression to HC1 standard errors because there are only five control-state clusters. That underscores the broader inferential problem rather than solving it.
- The placebo sample (7,969 observations) and trimmed-window sample (15,759) should be described more clearly, since these are central to the identification argument.
- The paper should clarify whether suppressed QCEW cells induce differential sample composition across states/sectors/time, especially for small sectors like Management. Composition changes could matter in a county-sector panel.

## 3. Robustness and alternative explanations

### A. Some useful checks are included, but they do not yet resolve core concerns

Positive aspects:
- pre-COVID restriction,
- leave-one-state-out,
- sector × quarter fixed effects,
- timing and state permutation tests,
- event study.

These are valuable. But most robustness checks leave the main unresolved issues untouched: pre-trends, few-cluster inference, and exposure-measure validity.

### B. The placebo result should be treated as a central challenge, not one robustness line

The placebo treatment in 2017Q1 is significant and positive. This is not a routine nuisance; it is a direct challenge to the identifying assumption. The paper’s response—drop 2017–2018 and proceed—is only partly persuasive.

A stronger robustness section would include:
- formal pre-trend tests over the whole pre-period,
- alternative leads around 2018 litigation milestones,
- stacked/event-study specifications allowing anticipation,
- and sensitivity to different pre-period endpoints.

### C. Excluding Administrative Services is not a convincing robustness check

This “robustness” makes the coefficient larger (-19.8%). But because Administrative Services is one of the highest-exposure sectors and also one that does not fit the treatment story, excluding it risks looking like ex post alignment of the data with the hypothesis. This check should not be used as evidence that the baseline is “conservative.” Instead it should motivate a redesign or revalidation of the exposure measure.

### D. Mechanism claims are currently ahead of the evidence

The paper is mostly careful in the mechanisms section, but several interpretations go beyond what the design can show:
- “litigation tax,”
- “cross-state adjustment,”
- “technology substitution,”
- “organizational fragmentation.”

These are plausible conceptual interpretations, not identified mechanisms. The paper should keep them clearly labeled as hypotheses. Right now some passages—especially in the introduction and discussion—sound more definitive than warranted.

### E. External validity is limited and should be stated more sharply

This is a single-state legal shock, in a specific privacy-law context, estimated primarily in border counties and over a period that includes COVID and later 2024 amendments. External validity to other enforcement architectures or other state privacy statutes is therefore limited. The discussion of “the twenty-state privacy wave” is interesting, but the extrapolation is stronger than the evidence supports.

## 4. Contribution and literature positioning

The topic is important and potentially novel: the labor-market incidence of activating private enforcement through a court ruling. That is a real contribution if the empirical design is tightened.

That said, the literature positioning could be improved in two ways.

### A. Methodological literature on few-cluster/policy-shock inference is underdeveloped

Given the design, the paper should engage directly with the inferential literature on few treated units / few clusters. Concrete references to consider:
- Cameron, Gelbach, and Miller (2008) on bootstrap-based improvements in clustered inference,
- Conley and Taber (2011) on inference with few policy changes,
- MacKinnon and Webb (2017, 2020) on wild bootstrap/randomization with few clusters,
- Ferman and Pinto (2019) and related work on inference in DiD with few groups.

These are not optional citations here; they are central to the paper’s validity.

### B. The privacy-regulation and BIPA-specific literature could be more complete

The paper cites broad privacy references, but should engage more directly with empirical work on privacy regulation, digital platform regulation, and BIPA/compliance/litigation where available. If there is an emerging legal-econ literature on BIPA settlements, technology adoption, or biometric privacy compliance, it should be cited and used to validate exposure measurement and mechanism.

### C. Continuous-treatment DiD / DDD literature

Because the identifying variation comes from continuous exposure, the paper would benefit from referencing work on treatment-intensity DiD and clarifying the interpretation of the coefficient under heterogeneous effects and noisy exposure measurement.

## 5. Results interpretation and claim calibration

### A. The paper overstates the strength of the evidence

Given:
- the significant placebo,
- the sensitivity to trend controls,
- the null all-counties estimate,
- the weak randomization-inference results,
- and the indirect exposure measure,

the paper cannot currently support claims like “demonstrating that enforcement architecture ... determines the economic incidence of regulation” (Abstract) or “the enforcement mechanism is the policy” (Conclusion). Those are much too strong relative to the evidence.

A more defensible claim would be: the paper presents suggestive evidence that the activation of private enforcement under BIPA may have reduced employment in more exposed sectors in Illinois border counties.

### B. Magnitudes should be presented more carefully

The “one-unit increase in exposure” interpretation is awkward because the support is coarse and the top values are driven by a handful of sectors. Readers will naturally translate this into moving from Accommodation (0) to Information (1), but the paper should be clearer that this is effectively a comparison across a small number of broad sector bins, not a finely measured continuous margin.

Similarly, the Management estimate (-34.4%) is based on a small sample and fragile inference; it should not be highlighted equally with more plausible sectors.

### C. Policy implications are too expansive

The policy discussion generalizes from Illinois BIPA to broad classes of private enforcement in antitrust, civil rights, environmental law, and multi-state privacy reforms. The conceptual analogy is interesting, but the empirical evidence here is too context-specific to justify such sweeping implications. The paper should scale back to a narrower claim about one important but distinctive enforcement design.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

1. **Rebuild the inferential framework for few clusters**
   - **Why it matters:** The current conventional clustered SEs with six state clusters are not reliable, and the paper’s strongest claims depend on them.
   - **Concrete fix:** Make small-sample-valid inference primary. Report wild-cluster bootstrap-t and/or carefully designed randomization-inference p-values for all main specifications. Relegate conventional clustered SEs to appendix or clearly label them as unreliable benchmarks.

2. **Address the pre-trend/anticipation problem as a core identification issue**
   - **Why it matters:** The significant 2017 placebo and 2018 event-study movement directly challenge the identifying assumption.
   - **Concrete fix:** Reframe the trimmed-window estimate as the main specification, test alternative treatment dates tied to litigation milestones, report formal pre-trend assessments, and explore specifications that allow anticipation starting in 2018.

3. **Strengthen validation of the exposure measure**
   - **Why it matters:** The treatment-intensity proxy is central, yet currently constructed post-treatment and mismatched to realized litigation in at least one high-exposure sector.
   - **Concrete fix:** Use pre-treatment O*NET vintages if possible; validate exposure against actual BIPA defendant industry composition, biometric time-clock adoption, or other independent industry-level measures; justify or redesign the preemption discounts; and stop treating exclusion of Administrative Services as validation.

4. **Clarify what population/effect is actually identified**
   - **Why it matters:** The all-counties estimate is null, while the border estimate is negative and neighboring controls also decline.
   - **Concrete fix:** Recast the paper explicitly as estimating effects in border labor markets unless stronger statewide evidence is produced. Add analyses that probe border-pair comparability and spillovers.

5. **Recalibrate headline claims**
   - **Why it matters:** Current rhetoric exceeds what the evidence supports.
   - **Concrete fix:** Rewrite the abstract/introduction/conclusion to reflect suggestive rather than definitive causal evidence unless inferential and identification concerns are substantially resolved.

### 2. High-value improvements

1. **Add richer spatial controls/comparisons**
   - **Why it matters:** Border-only estimates may reflect local confounds.
   - **Concrete fix:** Implement matched county-pair models, border-segment fixed effects, or commuting-zone analyses; show robustness to dropping major metro border areas; consider distance-to-border gradients.

2. **Show sensitivity to sector composition and suppression**
   - **Why it matters:** QCEW suppression and small-sector composition could distort county-sector panels.
   - **Concrete fix:** Report missing/suppressed-cell patterns by state-sector-time and test whether results are robust to balanced panels or sector exclusions.

3. **Provide more disciplined event-study evidence**
   - **Why it matters:** Dynamic treatment timing is central to the narrative.
   - **Concrete fix:** Report lead and lag coefficients in a table with valid inference, plus a joint test of pre-treatment leads.

4. **Separate reduced-form from mechanism more sharply**
   - **Why it matters:** The paper currently invites readers to over-interpret the channel.
   - **Concrete fix:** Move “litigation tax,” relocation, technology substitution, and organizational-fragmentation language into a clearly labeled interpretation section and avoid causal mechanism wording absent direct evidence.

### 3. Optional polish

1. **Tighten the contribution relative to the prior version and close substitutes**
   - **Why it matters:** Readers need to know exactly what is new here.
   - **Concrete fix:** Add a short paragraph distinguishing this paper from prior BIPA/privacy and regulation-employment papers.

2. **Present magnitude in more transparent sector comparisons**
   - **Why it matters:** “One-unit increase in exposure” is abstract.
   - **Concrete fix:** Translate effects into a few realistic sector contrasts, while emphasizing the coarse support and uncertainty.

3. **Reduce emphasis on the 2024 amendments analysis**
   - **Why it matters:** Two post-amendment quarters are not informative.
   - **Concrete fix:** Move this to an appendix or label it explicitly as preliminary and non-diagnostic.

## 7. Overall assessment

### Key strengths
- Important and policy-relevant question.
- Clever use of a judicial ruling as a discrete enforcement shock.
- Promising DDD structure that exploits cross-industry exposure heterogeneity.
- Transparent discussion of some limitations, including pre-trends and few clusters.
- QCEW data and border-county framing are sensible starting points.

### Critical weaknesses
- Main causal identification is undermined by a significant placebo and localized pre-trend.
- Inference is not publication-grade with only six state clusters; the paper’s strongest statistical claims rely on invalid conventional asymptotics.
- Randomization inference is substantially weaker than the paper’s headline rhetoric.
- The exposure index is post-treatment, indirectly measured, and imperfectly aligned with realized litigation exposure.
- Interpretation and policy claims overreach relative to the evidence.
- The border-only negative result combined with null statewide results and negative neighboring-border coefficients leaves the substantive interpretation unresolved.

### Publishability after revision
I do not think this paper is ready for acceptance or minor revision. But I do think it is potentially salvageable. The underlying idea is strong enough to justify a substantial reworking. A successful revision would need to rebuild inference, sharpen identification around the 2018/2019 timing, validate treatment intensity more convincingly, and scale claims to what the design can actually support.

DECISION: MAJOR REVISION